Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
European Urology
|
April 15, 2000
RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment
L Weissbach, R Bussar-Maatz, H Flechtner, et al.
Onkologie
|
October 1, 1989
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'
W Queisser, H Flechtner, M E Heim, et al.
Arzneimittel-Forschung
|
June 1, 1989
Assessment of the preclinical activity of budotitane in three different transplantable tumor systems, its lack of mutagenicity, and first results of clinical phase I studies
B K Keppler, M E Heim, H Flechtner, et al.
Onkologie
|
February 1, 1990
[Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group]
S Verhees, H Flechtner, W Queisser, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 3, 2003
Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)
J U Rüffer, H Flechtner, P Tralls, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie
|
June 1, 1993
[Documentation of psychopathologic findings: a procedure for the evaluation of psychological disorders in children and adolescents]
M Döpfner, G Lehmkuhl, W Berner, et al.
Seminars in Oncology
|
February 1, 1989
Experience of a German multicenter study group with ifosfamide in small cell lung cancer
K Havemann, M Wolf, P Drings, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2005
Health related quality of life outcomes in cancer clinical trials
A Bottomley, H Flechtner, F Efficace, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2002
Hodgkin's disease in the elderly: current status and future directions
S J Proctor, J U Rueffer, B Angus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1991
Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients
M Wolf, M Pritsch, P Drings, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
European Urology
|
April 15, 2000
RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment
L Weissbach, R Bussar-Maatz, H Flechtner, et al.
Onkologie
|
October 1, 1989
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'
W Queisser, H Flechtner, M E Heim, et al.
Arzneimittel-Forschung
|
June 1, 1989
Assessment of the preclinical activity of budotitane in three different transplantable tumor systems, its lack of mutagenicity, and first results of clinical phase I studies
B K Keppler, M E Heim, H Flechtner, et al.
Onkologie
|
February 1, 1990
[Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group]
S Verhees, H Flechtner, W Queisser, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 3, 2003
Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)
J U Rüffer, H Flechtner, P Tralls, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie
|
June 1, 1993
[Documentation of psychopathologic findings: a procedure for the evaluation of psychological disorders in children and adolescents]
M Döpfner, G Lehmkuhl, W Berner, et al.
Seminars in Oncology
|
February 1, 1989
Experience of a German multicenter study group with ifosfamide in small cell lung cancer
K Havemann, M Wolf, P Drings, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2005
Health related quality of life outcomes in cancer clinical trials
A Bottomley, H Flechtner, F Efficace, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2002
Hodgkin's disease in the elderly: current status and future directions
S J Proctor, J U Rueffer, B Angus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1991
Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients
M Wolf, M Pritsch, P Drings, et al.
Page
of 4